Article Text

Download PDFPDF

Increased muscle FDG-PET uptake in dermatomyositis
  1. Dimitri Renard1,
  2. Laura Chiper1,
  3. Laurent Collombier2,
  4. Pierre Labauge1
  1. 1Department of Neurology, CHU Nîmes, Hôpital Caremeau, Place du Pr Debré, Nîmes, France
  2. 2Department of Nuclear Medicine, CHU Nîmes, Hôpital Caremeau, Place du Pr Debré, Nîmes, France
  1. Correspondence to Dr Dimitri Renard, Department of Neurology, CHU Nîmes, Hôpital Caremeau, Place du Pr Debré, 30029 Nîmes Cedex 4, France; dimitrirenard{at}hotmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

A 55-year-old patient presented with progressive proximal tetraparesis since 2 months associated with erythematous rash and cuticular changes. Creatine kinase levels were elevated (2400 IU/l). Electromyography showed fibrillation and positive sharp wave potentials. Deltoid muscle biopsy showed evidence of dermatomyositis. Whole body fluorodeoxyglucose positron emission tomography (FDG-PET), performed to determine associated malignancy, did not show malignancy but showed increased muscular uptake (figure 1A). Oral prednisone 60 mg and azathioprine 100 mg was started. Two months later, muscle force and muscular FDG-PET uptake nearly normalised (figure 1B). Initial increased muscular FDG-PET uptake was probably related to myositis.1 Other possible conditions associated with increased muscular FDG-PET uptake include exertion, increased physiological uptake, hypoglycaemia and immunosuppressive therapy.2

Figure 1

Initial whole body FDG-PET showing diffuse, increased, proximal predominant, muscular uptake (A, arrows). Focal increased uptake in the proximal right arm (A, arrowhead) was probably related to the right deltoid muscle biopsy 3 weeks earlier. Two months later, whole body FDG-PET nearly normalised (B).

References

View Abstract

Footnotes

  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.